76 related articles for article (PubMed ID: 19800793)
1. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
Lee JY; Yu J; Cho WJ; Ko H; Kim YC
Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.
Chambers LJ; Stevens AJ; Moses AP; Michel AD; Walter DS; Davies DJ; Livermore DG; Fonfria E; Demont EH; Vimal M; Theobald PJ; Beswick PJ; Gleave RJ; Roman SA; Senger S
Bioorg Med Chem Lett; 2010 May; 20(10):3161-4. PubMed ID: 20399651
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.
Lee GE; Lee HS; Lee SD; Kim JH; Kim WK; Kim YC
Bioorg Med Chem Lett; 2009 Feb; 19(3):954-8. PubMed ID: 19110420
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.
Nelson DW; Sarris K; Kalvin DM; Namovic MT; Grayson G; Donnelly-Roberts DL; Harris R; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2008 May; 51(10):3030-4. PubMed ID: 18438986
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor.
Kim JH; Jeong PH; Lee JY; Lee JH; Kim YJ; Kim YC
Bioorg Med Chem; 2015 Apr; 23(8):1808-16. PubMed ID: 25797164
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.
Lee WG; Lee SD; Cho JH; Jung Y; Kim JH; Hien TT; Kang KW; Ko H; Kim YC
J Med Chem; 2012 Apr; 55(8):3687-98. PubMed ID: 22400713
[TBL] [Abstract][Full Text] [Related]
10. Characterization of ATP-gated P2X7 receptors in fish provides new insights into the mechanism of release of the leaderless cytokine interleukin-1 beta.
López-Castejón G; Young MT; Meseguer J; Surprenant A; Mulero V
Mol Immunol; 2007 Feb; 44(6):1286-99. PubMed ID: 16837047
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis.
Bruno O; Brullo C; Bondavalli F; Schenone S; Ranise A; Arduino N; Bertolotto MB; Montecucco F; Ottonello L; Dallegri F; Tognolini M; Ballabeni V; Bertoni S; Barocelli E
J Med Chem; 2007 Jul; 50(15):3618-26. PubMed ID: 17608466
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists.
Florjancic AS; Peddi S; Perez-Medrano A; Li B; Namovic MT; Grayson G; Donnelly-Roberts DL; Jarvis MF; Carroll WA
Bioorg Med Chem Lett; 2008 Mar; 18(6):2089-92. PubMed ID: 18272366
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.
Baraldi PG; del Carmen Nuñez M; Morelli A; Falzoni S; Di Virgilio F; Romagnoli R
J Med Chem; 2003 Apr; 46(8):1318-29. PubMed ID: 12672232
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release.
Bernardino L; Balosso S; Ravizza T; Marchi N; Ku G; Randle JC; Malva JO; Vezzani A
J Neurochem; 2008 Jul; 106(1):271-80. PubMed ID: 18384650
[TBL] [Abstract][Full Text] [Related]
16. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
17. Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.
Balachandran S; Rodge A; Gadekar PK; Yadav VN; Kamath D; Chetrapal-Kunwar A; Bhatt P; Srinivasan S; Sharma S; Vishwakarma RA; Dagia NM
Bioorg Med Chem Lett; 2009 Aug; 19(16):4773-6. PubMed ID: 19592246
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists.
Gleave RJ; Walter DS; Beswick PJ; Fonfria E; Michel AD; Roman SA; Tang SP
Bioorg Med Chem Lett; 2010 Aug; 20(16):4951-4. PubMed ID: 20634071
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an assay for P2X7 receptor-mediated cell death.
Lee SY; Jo S; Lee GE; Jeong LS; Kim YC; Park CS
Mol Cells; 2006 Oct; 22(2):198-202. PubMed ID: 17085972
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.
Morytko MJ; Betschmann P; Woller K; Ericsson A; Chen H; Donnelly-Roberts DL; Namovic MT; Jarvis MF; Carroll WA; Rafferty P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2093-6. PubMed ID: 18272365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
